Review of community pharmacy staff educational needs for supporting mental health consumers and carers

Community Mental Health Journal

Volumn 50, Issue 1, 2014, Pages 59-67

  Mey, Amary ^a   Fowler, Jane L ^a   Knox, Kathy ^a   Shum, David H K ^a   Fejzic, Jasmina ^a   Hattingh, Laetitia ^a,b   McConnell, Denise ^a   Wheeler, Amanda ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b CURTIN UNIVERSITY   (Australia)

Author keywords

Carer; Community pharmacy; Consumer; Education needs; Mental health; Pharmacist

Indexed keywords

PSYCHOTROPIC AGENT;

CAREGIVER; CURRICULUM; EDUCATION; HEALTH PERSONNEL ATTITUDE; HUMAN RELATION; INTERPERSONAL COMMUNICATION; MANPOWER; MEDICAL PROFESSION; MENTAL DISEASE; PATIENT EDUCATION; PHARMACY; PREJUDICE; PROFESSIONAL COMPETENCE; REVIEW;

ATTITUDE OF HEALTH PERSONNEL; CAREGIVERS; COMMUNICATION; CURRICULUM; HEALTH OCCUPATIONS; MENTAL DISORDERS; PATIENT EDUCATION AS TOPIC; PATIENT MEDICATION KNOWLEDGE; PHARMACIES; PREJUDICE; PROFESSIONAL COMPETENCE; PROFESSIONAL-FAMILY RELATIONS; PROFESSIONAL-PATIENT RELATIONS; PSYCHOTROPIC DRUGS;

EID: 84895056767     PISSN: 00103853     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10597-012-9580-4     Document Type: Review

References (75)

1. Adler, D. A.; Bungay, K. M.; Wilson, I. B.; Pei, Y.; Supran, S.; Peckham, E.; et al. (2004). The impact of a pharmacist intervention on 6-month outcomes in depressed primary care patients. General Hospital Psychiatry, 26(3), 199-209.
2. Angermeyer, M. C.; Dietrich, S. (2006). Public beliefs about and attitudes towards people with mental illness: A review of population studies. Acta Psychiatrica Scandinavica, 113(3), 163-179.
3. Angermeyer, M. C.; Matschinger, H. (2003). The stigma of mental illness: Effect of labelling on public attitudes towards people with mental disorders. Acta Psychiatrica Scandinavica, 108, 304-309.
4. Australian Institute of Health and Welfare. (2010a). Australia's health 2010. Retrieved January 30, 2012, from http://www.aihw.gov.au/publication- detail/?id=6442468375.
5. Australian Institute of Health and Welfare. (2010b). Mental health services in Australia 2007-2008. Mental Health Series Number 12. Cat N. HSE 88. Retrieved February 23, 2012, from http://www.aihw.gov.au/publication-detail/?id= 6442468381&tab=2.
6. Bell, J. S.; Aaltonen, S. E.; Airaksinen, M. S.; Volmer, D.; Gharat, M. S.; Muceniece, R.; et al. (2010). Determinants of mental health stigma among pharmacy students in Australia, Belgium, Estonia, Finland, India and Latvia. [Comparative Study]. International Journal of Social Psychiatry, 56(1), 3-14.
7. Bell, J. S.; McLachlan, A. J.; Aslani, P.; Whitehead, P.; Chen, T. F. (2005). Community pharmacy services to optimise the use of medications for mental illness: A systematic review. Australia and New Zealand Health Policy, 2, 29-40. doi: 10.1186/1743-8462-2-29.
8. Bell, J. S.; Rosen, A.; Aslani, P.; Whitehead, P.; Chen, T. (2007). Developing the role of pharmacists as members of community mental health teams: Perspectives of pharmacists and mental health professionals. Research in Social and Administrative Pharmacy, 3, 392-409.
9. Benrimoj, S. I.; Frommer, M. S. (2004). Commuity pharmacy in Australia. Australian Health Review, 28, 238-246.
10. Black, E.; Murphy, A. L.; Gardner, D. M. (2009). Community pharmacist services for people with mental illnesses: Preferences, satisfaction, and stigma. Psychiatric Services, 60(8), 1123-1127.
11. Botega, N.; Mann, A.; Blizard, R.; Wilkinson, G. (1992). General practitioners and depression: First use of the Depression Attitude Questionnaire. International Journal of Methods in Psychiatric Research, 4, 169-180.
12. Brook, O. H.; Stalman, W.; Nieuwenhuyse, H.; Bakker, B.; de Haan, M. (2005). A pharmacy-based coaching program to improve adherence to antidepressant treatment among primary care patients. Psychiatric Services, 56(4), 487-489.
13. Brook, O. H.; Van Hout, H. P. J.; Nieuwenhuyse, H.; De Haan, M. (2003). Effects of coaching by community pharmacists on psychological symptoms of antidepressant users: A randomised controlled trial. European Neuropsychopharmacology, 13(5), 347-354. doi: 10.1016/s0924-977x(03)00031-2.
14. Bryant, S. G.; Guernsey, B. G.; Pearce, E. L.; Hokanson, J. A. (1985). Pharmacists' perceptions of mental health care, psychiatrists, and mentally ill patients. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.]. American Journal of Hospital Pharmacy, 42(6), 1366-1369.
15. Caldwell, T. M.; Jorm, A. F. (2000). Mental health nurses' beliefs about interventions for schizophrenia and depression: A comparison with psychiatrists and the public. Australian and New Zealand Journal of Psychiatry, 34(4), 602-611.
16. Cates, M. E.; Burton, A. R.; Woolley, T. W. (2005). Attitudes of pharmacists toward mental illness and providing pharmaceutical care to the mentally ill. Annals of Pharmacotherapy, 39(9), 1450-1455.
17. Chong, W. W.; Aslani, P.; Chen, T. F. (2011). Effectiveness of interventions to improve antidepressant medication adherence: A systematic review. International Journal of Clinical Practice, 65(9), 954-975. doi: 10.1111/j.1742-1241.2011.02746.x.
18. Corrigan, P. W.; Watson, A. C. (2002). Understanding the impact of stigma on people with mental illness. World Psychiatry, 1(1), 16-20.
19. Crisp, A. H.; Gelder, M. G. (2000). Stigmatisation of people with mental illness. British Journal of Psychiatry, 177, 4-7.
20. Crockett, J.; Taylor, S.; Grabham, A.; Stanford, P. (2006). Patient outcomes following an intervention involving community pharmacists in the management of depression. Australian Journal of Rural Health, 14(6), 263-269. doi: 10.1111/j.1440-1584.2006.00827.x.
21. Crump, K.; Boo, G.; Liew, F. S.; Olivier, T.; So, C.; Sung, J. Y.; et al. (2011). New Zealand community pharmacists' views of their roles in meeting medicine-related needs for people with mental illness. Research in Social and Administrative Pharmacy, 7(2), 122-133. doi: 10.1016/j.sapharm.2010.03.006.
22. Desplenter, F.; Simoens, S.; Laekeman, G. (2006). The impact of informing psychiatric patients about their medication: A systematic review. Pharmacy World & Science, 28(6), 329-341. doi: 10.1007/s11096-006-9054-2.
23. Ewan, M. A.; Greene, R. J. (2001). Evaluation of mental health care interventions made by three community pharmacists: A pilot study. International Journal of Pharmacy Practice, 9(4), 225-234. doi: 10.1111/j.2042-7174.2001. tb01053.x.
24. Fan, C. (1999). A comparison of attitudes towards mental illness and knowledge of mental health services between Australian and Asian students. Community Mental Health Journal, 35(1), 47-56. doi: 10.1023/a:1018795925455.
25. Finley, P. R.; Crismon, L.; Rush, A. J. (2003). Evaluating the impact of pharmacists in mental health: A systematic review. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 23(12), 1634-1644.
26. Gardner, D.; Murphy, A.; Woodman, A.; Connelly, S. (2001). Community pharmacy services for antidepressant users. International Journal of Pharmacy Practice, 9(4), 217-224. doi: 10.1111/j.2042-7174.2001.tb01052.x.
27. George, P. P.; Molina, J. A. D.; Cheah, J.; Chan, S. C.; Lim, B. P. (2010). The evolving role of the community pharmacist in chronic disease management: A literature review. Annals of the Academy of Medicine, Singapore, 39(11), 861-867.
28. Gilbert, A. L.; Roughead, E. E.; Beilby, J.; Mott, K.; Barratt, J. D. (2002). Collaborative medication management services: Improving patient care. Medical Journal of Australia, 177, 189-192.
29. Gilbody, S.; Bower, P.; Fletcher, J.; Richards, D.; Sutton, A. J. (2006). Collaborative care for depression: A cumulative meta-analysis and review of longer-term outcomes. Archives of Internal Medicine, 166(21), 2314-2321. doi: 10.1001/archinte.166.21.2314.
30. Gisev, N.; Bell, J. S.; O'Reilly, C. L.; Rosen, A.; Chen, T. F. (2010). An expert panel assessment of comprehensive medication reviews for clients of community mental health teams
31. Hamann, J.; Cohen, R.; Leucht, S.; Busch, R.; Kissling, W. (2005). Do patients with schizophrenia wish to be involved in decisions about their medical treatment? [Comparative Study Research Support, Non-U.S. Gov't]. American Journal of Psychiatry, 162(12), 2382-2384.
32. Hammond, R. W.; Schwartz, A. H.; Campbell, M. J.; Remington, T. L.; Chuck, S.; Blair, M. M.; et al. (2003). Collaborative drug therapy management by pharmacists. Pharmacotherapy, 23(9), 1210-1225.
33. Happell, B.; Manias, E.; Roper, C. (2004). Wanting to be heard: Mental health consumers' experiences of information about medication. International Journal of Mental Health Nursing, 13(4), 242-248.
34. Harris, D.; Anderson, C. (2003). Interventions by community pharmacists for older people with mental health problems: Are they appropriate? International Journal of Pharmacy Practice, 11(suppl), R56.
35. Healthcare Management Advisors. (2010). Managing mental illness and promoting and sustaining recovery: The role of community pharmacy. Retrieved April 6, 2011, from http://www.guild.org.au/iwov-resources/documents/The-Guild/ PDFs/CPA%20and%20Programs/4CPA%20General/2007%2008-07/ RFT0807%20MMI%20Full%20Final%20Report%20FINAL.pdf.
36. Hirai, M.; Clum, G. A. (2000). Development, reliability, and validity of the beliefs toward Mental Illness Scale. Journal of Psychopathology and Behavioural Assessment, 22(3), 221-236. doi: 10.1023/A:1007548432472.
37. Human Capital Alliance. (2008). Pharmacy workforce planning study: Initial supply report. Retrieved January 30, 2012, from http://www. humancapitalalliance.com.au/documents/PH08-Full%20Final%20Report.pdf.
38. Jorm, A. F.; Korten, A. E.; Jacomb, P. A.; Christensen, H.; Henderson, S. (1999). Attitudes towards people with a mental disorder: A survey of the Australian public and health professionals. Australia and New Zealand Journal of Psychiatry, 33, 77-83. doi: 10.1046/j.1440-1614.1999.00513.x.
39. Jorm, A. F.; Korten, A. E.; Jacomb, P. A.; Rodgers, B.; Pollitt, P. (1997). Beliefs about the helpfulness of interventions for mental disorders: A comparison of general practitioners, psychiatrists and clinical psychologists. Australia and New Zealand Journal of Psychiatry, 31(6), 844-851.
40. Kai, J.; Crosland, A. (2001). Perspectives of people with enduring mental ill health from a community-based qualitative study. [Research Support, Non-U.S. Gov't]. The British Journal of General Practice, 51(470), 730-736.
41. Kassam, A.; Glozier, N.; Leese, M.; Henderson, C.; Thornicroft, G. (2010). Development and responsiveness of a scale to measure clinicians' attitudes to people with mental illness (medical student version). Acta Psychiatrica Scandinavica, 122(2), 153-161. doi: 10.1111/j.1600-0447.2010.01562. x.
42. Kobau, R.; Dilorio, C.; Chapman, D.; Delvecchio, P.; S. C. M. I. S. P. Members. (2010). Attitudes about mental illness and its treatment: Validation of a generic scale for public health surveillance of mental illness associated stigma. Community Mental Health Journal, 46, 164-176.
43. Koo, M.; Krass, I.; Aslani, P. (2002). Consumer opinions on medicines information and factors affecting its use: An Australian experience. International Journal of Pharmacy Practice, 10, 107-114. doi: 10.1111/j.2042-7174.2002.tb00595.x.
44. Lauber, C.; Nordt, C.; Braunschweig, C.; Rössler, W. (2006). Do mental health professionals stigmatize their patients? Acta Psychiatrica Scandinavica, 113, 51-59. doi: 10.1111/j.1600-0447.2005.00718.x.
45. Lingam, R.; Scott, J. (2002). Treatment non-adherence in affective disorders. [Review]. Acta Psychiatrica Scandinavica, 105(3), 164-172.
46. Link, B. G.; Cullen, F. T.; Frank, J.; Wozniak, J. F. (1987). The social rejection of former mental-patients: Understanding why labels matter. American Journal of Sociology, 92(6), 1461-1500.
47. Mant, A.; Rendle, V. A.; Hall, W. D.; Mitchell, P. B.; Montgomery, W. S.; McManus, P. R.; et al. (2004). Making new choices about antidepressants in Australia: The long view 1975-2002. Medical Journal of Australia, 181(7), s21-s24.
48. Maslen, C. L.; Rees, L.; Redfern, P. H. (1996). Role of the community pharmacist in the care of patients with chronic schizophrenia in the community. International Journal of Pharmacy Practice, 4(4), 187-195. doi: 10.1111/j.2042-7174.1996.tb00867.x.
49. McCall, L.; Clarke, D. M.; Rowley, G. (2002). A questionnaire to measure general practitioners' attitudes to their role in the management of patients with depression and anxiety. Australian Family Physician, 31(3), 299-303.
50. Meagher, D.; Moran, M. (2003). Sub-optimal prescribing in an adult community mental health service: Prevalence and determinants. Psychiatric Bulletin, 27(7), 266-270. doi: 10.1192/pb.02-291.
51. Mental Health Branch Queensland Health. (2008). The Queensland plan for mental health 2007-2017. Retrieved April 6, 2011, from http://www.health.qld. gov.au/mentalhealth/abt-us/qpfmh/08132-qpfmh07.pdf.
52. Mental Health Commission. (2004). Our lives in 2014: A recovery vision from people with experience of mental illness for the second mental health plan and the development of the health and social sectors. Retrieved 06 April, 2011, from http://www.maryohagan.com/resources/Text-Files/Our%20Lives%20in%202014.pdf.
53. Nordt, C.; Rossler, W.; Lauber, C. (2006). Attitudes of mental health professionals towards people with schizophrenia and major depression. Schizophrenia Bulletin, 32(4), 709-714.
54. O'Reilly, C.; Bell, J. S.; Chen, T. F. (2010). Pharmacists' beliefs about treatments and outcomes of mental disorders: A mental health literacy survey. Australia and New Zealand Journal of Psychiatry, 44(12), 1089-1096.
55. Pharmacy Guild of Australia. (2010). The roadmap: The strategic direction for community pharmacy. Retrieved April 6, 2011, from http://www.guild.org.au/ iwov-resources/documents/The-Guild/PDFs/News%20and%20Events/Publications/ The%20Roadmap/Roadmap.pdf.
56. Pharmacy Guild of Australia. (2012). Pharmacy assistant training. Retrieved April 1, 2012, from http://www.guildtraining.com.au/sites/Guild- Training/Pharmacy%20Assistants%20Training/Pharmacy%20Assistant%20Training.page.
57. Phokeo, V.; Sproule, B.; Raman-Wilms, L. (2004). Community pharmacists' attitudes toward and professional interactions with users of psychiatric medication. Psychiatric Services, 55(12), 1434-1436. doi: 10.1176/appi.ps.55.12. 1434.
58. Priest, R. G.; Vize, C.; Roberts, A.; Roberts, M.; Tylee, A. (1996). Lay people's attitudes to treatment of depression: Results of opinion poll for Defeat Depression Campaign just before its launch. British Medical Journal, 313, 858-859.
59. SANE Media Centre. (2011). Stigma hurtful and common for people with mental illness. Retrieved January 30, 2012, from http://www.sane.org/releases- 2011/1056-stigma-hurtful-and-common-for-people-with-mental-illness.
60. Scheerder, G.; De Coster, I.; Van Audenhove, C. (2008). Pharmacists' role in depression care: A survey of attitudes, current practices, and barriers. Psychiatric Services, 59(10), 1155-1160. doi: 10.1176/appi.ps.59.10.1155.
61. Scheerder, G.; De Coster, I.; Van Audenhove, C. (2009). Community pharmacists' attitude toward depression: A pilot study. Research in Social and Administrative Pharmacy, 5, 242-252. doi: 10.1016/j.sapharm.2008.08.008.
62. Scheerder, G.; Van Audenhove, C.; Arensman, E.; Bernik, B.; Giupponi, G.; Horel, A.-C.; et al. (2011). Community and health professionals' attitude towards depression: A pilot study in nine EAAD countries. International Journal of Social Psychiatry, 57(387), 337-401. doi: 10.1177/0020764009359742.
63. Slade, T.; Johnston, A.; Oakley Browne, M. A.; Andrews, G.; Whiteford, H. (2009). 2007 national survey of mental health and wellbeing: Methods and key findings. Australian and New Zealand Journal of Psychiatry, 43(7), 594-605.
64. Tanskanen, P.; Airaksinen, M.; Tanskanen, A.; Enlund, H. (2000). Counselling patients on psychotropic medication: Physicians' opinions on the role of community pharmacists. Pharmacy World & Science, 22(2), 59-61.
65. University of South Australia. (2005). Consumer experiences, needs and expectations of community pharmacy. Retrieved April 6, 2011, from http://www.guild.org.au/iwov-resources/documents/The-Guild/PDFs/ CPA%20and%20Programs/3CPA%20General/2005-501/Final%20Rept-8Mar06.pdf.
66. Valenstein, M.; Kavanagh, J.; Lee, T.; Reilly, P.; Dalack, G. W.; Grabowski, J.; et al. (2011). Using a pharmacy-based intervention to improve antipsychotic adherence among patients with serious mental illness. Schizophrenia Bulletin, 37(4), 727-736.
67. Van Wijk, B. L.; Klungel, O. H.; Heerdink, E. R.; de Boer, A. (2005). Effectiveness of interventions by community pharmacists to improve patient adherence to chronic medication: A systematic review. Annals of Pharmacotherapy, 39, 1325-1330. doi: 10.1345/aph.1E027.
68. Volmer, D.; Maesalu, M.; Bell, J. (2008). Pharmacy students' attitudes toward and professional interactions with people with mental disorders. International Journal of Social Psychiatry, 54, 402-413.
69. Wahl, O. F. (1999). Mental health consumers' experience of stigma. Schizophrenia Bulletin, 25(3), 467-478.
70. Wahl, O. F. (2011). Stigma as a barrier to recovery from mental illness. Trends in Cognitive Sciences, 16(1), 9-10. doi: 10.1016/j.tics.2011.11.002.
71. World Health Organization. (2001). The world health report 2001: Mental health: New understanding, new hope. Retrieved April 6, 2011, from http://www.who.int/whr/2001/en/whr01-en.pdf.
72. World Health Organization. (2008a). The global burden of disease: 2004 update. Retrieved April 6, 2011, from http://www.who.int/healthinfo/global- burden-disease/GBD-report-2004update-full.pdf.
73. World Health Organization. (2008b). Integrating mental health into primary care: A global perspective. Retrieved January 30, 2012, from http://whqlibdoc.who.int/publications/2008/9789241563680-eng.pdf.
74. World Health Organization. (2008c). Mental health gap action programme: Scaling up care for mental, neurological and substance use disorders. Retrieved April 6, 2011, from http://whqlibdoc.who.int/publications/2008/9789241596206- eng.pdf.
75. Yeap, R.; Beevi, Z.; Lukman, H. (2008). Evaluating IMU communication skills training programme: Assessment tool development. [Evaluation Studies]. Medical Journal of Malaysia, 63(3), 244-246.